Phospholamban gene dosage effects in the mammalian heart

Circulation Research

Volumn 78, Issue 5, 1996, Pages 839-847

  Luo, Wusheng ^a   Wolska, Beata M ^b   Grupp, Ingrid L ^a   Harrer, Judy M ^a   Haghighi, Kobra ^a   Ferguson, Donald G ^a   Slack, Jay P ^a   Grupp, Gunter ^a   Doetschman, Thomas ^a   Solaro, R John ^b   Kranias, Evangelia G ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

cardiomyocytes; heart; phospholamban; sarcoplasmic reticulum; working heart preparation

Indexed keywords

PHOSPHOLAMBAN;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; DEPHOSPHORYLATION; DRUG EFFECT; GENE DOSAGE; HEART BEAT; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PERFORMANCE; IMAGE ENHANCEMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM;

EID: 9244255361     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.5.839     Document Type: Article

References (45)

1. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 1993;72: 463-469.
2. Feldman AM, Ray PE, Silan CM, Mercer JA, Minobe W, Bristow MR. Selective gene expression in failing human heart: quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation. 1991;83: 1866-1872.
3. Eschenhagen T, Mende U, Schmitz W, Scholz M. Changes in gene expression in terminal myocardial failure. Z Kardiol. 1992; 81(suppl 4):33-40.
4. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 1995;92:778-784.
5. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res. 1994;75: 401-409.
6. 2+-ATPase with phospholamban in phospholipid vesicles. J Biol Chem. 1990; 265:1702-1709.
7. Simmerman HKB, Collins JH, Theibert JL, Wegener AD, Jones LR. Sequence analysis of phospholamban: identification of phosphorylation sites and two major structural domains. J Biol Chem. 1986;261:13333-13341.
8. Raeymaekers L, Hofmann F, Casteels R. Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle. Biochem J. 1988;252:269-273.
9. Colyer J, Wang JH. Dependence of cardiac sarcoplasmic reticulum calcium pump activity on the phosphorylation status of phospholamban. J Biol Chem. 1991;266:17486-17493.
10. Hicks MJ, Shigekawa M, Katz AM. Mechanism by which cyclic adenosine 3′:5′-monophosphate-dependent protein kinase stimulates calcium transport in cardiac sarcoplasmic reticulum. Circ Res. 1979;44:384-391.
11. 2+ transport by phosphoprotein phosphatase activity associated with cardiac sarcoplasmic reticulum. J Biol Chem. 1985;260:11006-11010.
12. 2+ transport by cyclic 3′:5′-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum. Biochim Biophys Acta. 1985;844: 193-199.
13. 2+)-ATPase: mechanism of regulation and site of monoclonal antibody interaction. J Biol Chem. 1991;266:11270-11275.
14. 2+-pump ATPase. J Biol Chem. 1992;267: 1674-1679.
15. Tada M, Inui M, Yamada M, Kadoma MA, Kuzuya T, Abe H, Kakiuchi S. Effects of phospholamban phosphorylation catalyzed by adenosine 3′:5′-monophosphate- and calmodulin-dependent protein kinases on calcium transport ATPase of cardiac sarcoplasmic reticulum. J Mol Cell Cardiol. 1983;15:335-346.
16. Kirchberger MA, Borchman D, Kasinathan C. Proteolytic activation of the canine cardiac sarcoplasmic reticulum calcium pump. Biochemistry. 1986;25:5484-5492.
17. Kranias EG, Garvey JL, Srivastava RD, Solaro RJ. Phosphorylation and functional modifications of sarcoplasmic reticulum and myofibrils in isolated rabbit hearts stimulated with isoprenaline. Biochem J. 1985;226:113-121.
18. Kranias EG, Solaro RJ. Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart. Nature. 1982;298:182-184.
19. 2+-ATPase activity in guinea pig ventricles. J Biol Chem. 1983;258:464-471.
20. Miyakoda G, Yoshida A, Takisawa H, Nakamura T. β-Adrenergic regulation of contractility and protein phosphorylation in spontaneously beating isolated rat myocardial cells. J Biochem. 1987;102: 211-224.
21. Mundina de Weilenmann C, Vittone L, de Cingolani G, Mattiazi A. Dissociation between contraction and relaxation: the possible role of phospholamban phosphorylation. Basic Res Cardiol. 1987;82: 507-516.
22. Wegener AD, Simmerman KB, Lindemann JP, Jones LR. Phospholamban phosphorylation in intact ventricles. J Biol Chem. 1989; 264:11468-11474.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
24. Ganim JR, Luo W, Ponniah S, Grupp I, Kim HW, Ferguson DG, Kadambi V, Neumann JC, Doetschman T, Kranias EG. Mouse phospholamban gene expression during development in vivo and in vitro. Circ Res. 1992;71:1021-1030.
25. 2+ extrusion from the resting myocytes of guinea pig heart: comparison with rat. J Mol Cell Cardiol. 1993;25: 75-91.
26. Steadman BW, Moore KB, Spitzer KW, Bridge JHB. A video system for measuring motion in contracting heart cells. IEEE Trans Biomed Eng. 1988;35:264-272.
27. Grupp IL, Subramaniam A, Hewett TE, Robbins J, Grupp G. Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations. Am J Physiol. 1993;265:H1401-H1410.
28. Ng WA, Grupp IL, Subramaniam A, Robbins J. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res. 1991;68:1742-1750.
29. Grupp IL, Kranias EG, Harrer JM, Kiss E, Slack J, Koss KL, Edes I, Luo W, Grupp G. The contribution of phospholamban, a sarcoplasmic reticulum phosphoprotein, to myocardial contractility in health and disease. Heart Failure. 1995;11:48-61.
30. 2+ transport and myocardial relaxation. Circ Res. 1994;75:245-251.
31. Koss KL, Ponniah S, Jones WK, Grupp IL, Kranias EG. Differential phospholamban gene expression in murine cardiac compartments: molecular and physiological analyses. Circ Res. 1995;77: 342-353. Erratum published in Circ Res. 1995;77:1036.
32. Fugii J, Ueno A, Kitano K, Tanaka S, Kadoma M, Tada M. Complete complementary DNA-derived amino acid sequence of canine cardiac phospholamban. J Clin Invest. 1987;79:301-304.
33. Fujii J, Lytton J, Tada M, MacLennan DH. Rabbit cardiac and slow-twitch muscle express the same phospholamban gene. FEBS Lett. 1988;227:51-55.
34. Verboomen H, Wuytack D, Eggermont JA, De Jaegere S, Missiaen L, Raeymaekers L, Casteels R. cDNA cloning and sequencing of phospholamban from pig stomach smooth muscle. Biochem J. 1989; 262:353-356.
35. Tada M, Inui M, Yamada M, Kadoma MA, Kuzuya T, Abe H, Kakiuchi S. Effects of phospholamban phosphorylation catalyzed by adenosine 3′:5′-monophosphate- and calmodulin-dependent protein kinases on calcium transport ATPase of cardiac sarcoplasmic reticulum. J Mol Cell Cardiol. 1983;15:335-346.
36. Colyer J, Wang JH. Dependence of cardiac sarcoplasmic reticulum calcium pump activity on the phosphorylation status of phospholamban. J Biol Chem. 1991;266:17486-17493.
37. Louis CF, Turnquist J, Jarvis B. Phospholamban stoichiometry in canine cardiac muscle sarcoplasmic reticulum. Neurol Res. 1987;12: 937-941.
38. Szymanska G, Grupp IL, Slack JP, Harrer JM, Kranias EG. Alterations in sarcoplasmic reticulum calcium uptake, relaxation parameters and their responses to β-adrenergic agonists in the developing rabbit heart. J Mol Cell Cardiol. 1995;27:1819-1824.
39. Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn GW, Walsh RA, Kranias EG. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest. 1996;97:533-539.
40. 2+/calmodulin-dependent protein kinase. J Biol Chem. 1994;269:26492-26496.
41. Yoshida A, Takahashi M, Imagawa T, Shigekawa M, Takisawa H, Nakamura T. Phosphorylation of ryanodine receptors in rat myocytes during β-adrenergic stimulation. J Biochem. 1992;111: 186-190.
42. Presti CF, Jones LR, Lindemann JP. Isoproterenol-induced phosphorylation of a 15-kilodalton sarcolemmal protein in intact myocardium. J Biol Chem. 1985;260:3860-3867.
43. Movsesian MA, Bristow MR, Krall J. Calcium uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy. Circ Res. 1989;65:1141-1144.
44. 2+-uptake in sarcoplasmic reticulum from normal and failing hearts. J Clin Invest. 1990;85:1698-1702.
45. Bohm M, Reiger B, Schwinger RHG, Erdmann E. cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in nonfailing and failing myocardium. Cardiovasc Res. 1994; 28:1713-1719.